http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3763380-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cdb3dde3f56146def9ab8c36e470e1a8 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-168 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 |
| filingDate | 2018-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6de3e0402b9bbd03d068a15c11cc4b0a |
| publicationDate | 2021-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-3763380-A1 |
| titleOfInvention | Method for treating encephalopathy |
| abstract | The invention relates to medicine, specifically neurology, and can be used to treat patients who have encephalopathy of vascular, traumatic, inflammatory or other origin. In a method for treating encephalopathy by means of drug therapy, according to the invention, a patient's blood glucose level is lowered to 3.4-3.6 mmol/L by intravenous administration of insulin, then solutions of preparations in a single dose are administered intravenously and consecutively with a 30-second interval: first a solution of a vascular preparation having a pharmacological effect, then a solution of a preparation having a direct nootropic effect, then a solution of a peptide preparation and then a solution of a metabolic preparation, wherein one treatment is performed per week, with the total number of treatments being four procedures. In the method for treating encephalopathy, a solution of Cavinton or vinpocetine or trental or pentoxifylline is administered as the vascular preparation having a pharmacological effect, a solution of piracetam or Nootropil or Mexidol or Ceraxon is administered as the preparation having a direct nootropic effect, a solution of Cortexin or Cerebrolysin is administered as the peptide preparation, and a solution of Actovegin or Solcoseryl is administered as the metabolic preparation. The proposed method for treating encephalopathy provides a stable clinical effect by increasing the nootropic, vasoactive and neurotropic effectiveness of the medicinal preparations administered. |
| priorityDate | 2018-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 155.